Fax: (404) 778-4755
Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia
Article first published online: 19 APR 2012
Copyright © 2012 American Cancer Society
Volume 118, Issue 21, pages 5278–5282, 1 November 2012
How to Cite
Arellano, M., Pakkala, S., Langston, A., Tighiouart, M., Pan, L., Chen, Z., Heffner, L. T., Lonial, S., Winton, E. and Khoury, H. J. (2012), Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia. Cancer, 118: 5278–5282. doi: 10.1002/cncr.27494
- Issue published online: 19 OCT 2012
- Article first published online: 19 APR 2012
- Manuscript Accepted: 10 JAN 2012
- Manuscript Revised: 30 DEC 2011
- Manuscript Received: 26 AUG 2011
- 1Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study. J Clin Oncol. 2010; 28: 1766-1771., , , et al.
- 3A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties. Br J Haematol. 1999; 107: 69-79., , , et al.
- 4Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial. Blood. 2003; 101: 64-70., , , et al.